Efficacy of chemotherapy plus gefitinib treatment in advanced non-small-cell lung cancer patients following acquired resistance to gefitinib

Non-small-cell lung cancer (NSCLC) may exhibit oncogene addiction in patients who benefited from prior treatment with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs). Preclinical data suggested that EGFR addiction persists after the development of TKI resistance, leading ma...

Descripción completa

Detalles Bibliográficos
Autores principales: SONG, ZHENGBO, ZHANG, YIPING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915312/
https://www.ncbi.nlm.nih.gov/pubmed/24649264
http://dx.doi.org/10.3892/mco.2013.156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915312/
https://www.ncbi.nlm.nih.gov/pubmed/24649264
http://dx.doi.org/10.3892/mco.2013.156

Ejemplares similares